Swiss drug company Roche Holding increased its offer to acquire the rest of Genentech to $93 a share from $86.50.
WSJ.com: What's News US, Wall Street Journal
Fri, 03/06/2009 - 10:41am
Swiss drug company Roche Holding increased its offer to acquire the rest of Genentech to $93 a share from $86.50.